Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Solid Tumor, Adult: early-phase trial registry
48 of 73 indexed Solid Tumor, Adult trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #188 of 28,707 conditions by registered trial count.
73 US clinical trials · 48 currently recruiting · #188 of 28,707 conditions by registered trial count
Solid Tumor, Adult: 73 US clinical trials tracked, 48 recruiting.
Solid Tumor, Adult is the subject of 73 registered US clinical trials on ClinicalTrials.gov, 48 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 61 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 7 of these trials.
Enrollment posture brief
Registry condition solid-tumor-adult
OPEN 48 | RECR 66% | LATE 0 | EARLY 61 | RANK #188 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Hematopoietic and Lymphoid System Neoplasm (66% recruiting · 32 trials)
Solid Tumor, Adult lists 48 open slots (66% of 73 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Solid Tumor, Adult on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Solid Tumor, Adult is recruiting above its size-band peers.
48 of 73 indexed trials (65.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Solid Tumor, Adult trials is spread across many organizations.
Memorial Sloan Kettering Cancer Center accounts for 7 of 73 trials (9.6%). 60 distinct sponsors appear on at least one study for this condition label.
-
Typical Solid Tumor, Adult enrolment sits around 115 participants.
Median target enrolment is 115 among the 73 trials that report a genuine target (sentinel values excluded). 32 of those (43.8%) plan for fewer than 100 participants.
-
Solid Tumor, Adult research is mostly interventional.
69 interventional and 4 observational studies make up this index (94.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
73 total, page 2 of 2
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
Tyra Biosciences
NCT05544552
First-in-Human Study of ICT01 in Patients With Advanced Cancer
ImCheck Therapeutics
NCT04243499
Study to Evaluate D-1553 in Subjects With Solid Tumors
InventisBio Co.
NCT04585035
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
A2 Biotherapeutics
NCT05736731
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Cybrexa Therapeutics
NCT04902872
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
Indaptus Therapeutics
NCT05651022
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Nouscom SRL
NCT04041310
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Sensei Biotherapeutics
NCT05864144
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
HotSpot Therapeutics
NCT05662397
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Sarcoma Oncology Research Center
NCT04165330
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
NCT05678010
A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors
Axion Bio
NCT07159828
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Memorial Sloan Kettering Cancer Center
NCT04552288
A Monotherapy in Subjects With Advanced Solid Tumors
3D Medicines (Beijing) Co.
NCT04221204
A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial
ImmuneSensor Therapeutics
NCT06026254
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Ikena Oncology
NCT04200963
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Baptist Health South Florida
NCT03274661
A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer
TyrNovo
NCT04474470
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Relay Therapeutics
NCT05759949
Cannabis Use in Cancer Patients
University of Colorado, Denver
NCT03617692
A Study of DCR-STAT3 in Adults With Solid Tumors
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
NCT06098651
Study of FCN-437c in Patients With Advanced Solid Tumors
Fochon Pharmaceuticals
NCT03951116
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
NCT02717572
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Solid Tumor, Adult records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Solid Tumor, Adult trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Solid Tumor, Adult page
73 registered trials, 48 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 48 Solid Tumor, Adult trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Memorial Sloan Kettering Cancer Center sponsors the most Solid Tumor, Adult trials on record, review their full trial history before evaluating a specific study. See Memorial Sloan Kettering Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Solid Tumor, Adult condition card totals 73 registered trials; most-linked intervention Fulvestrant; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.